European Stocks Close Broadly Higher

European stocks closed broadly higher on Friday, buoyed by hopes of a slower Federal Reserve tightening cycle after softer-than-expected US October CPI data and China's relaxation of COVID-19 restrictions. While the pan-European Stoxx 600 saw modest gains and the DAX and CAC 40 rose, the UK's FTSE 100 declined. Key economic data included the UK's Q3 GDP contracting by 0.2%, its first decline since early 2021 (though better than forecast), and Germany's October CPI accelerating to an all-time high of 10.4% driven by energy and food prices.

Analysis

European equity markets exhibited a divergent and complex reaction to competing macro signals, closing broadly higher but with notable exceptions. The primary positive catalysts were external: softer-than-expected U.S. consumer price data fueled hopes for a less aggressive Federal Reserve, while China's easing of some COVID-19 restrictions improved the outlook for global growth. This optimism propelled Germany's DAX (+0.56%) and France's CAC 40 (+0.58%), but was insufficient to lift the UK's FTSE 100, which declined 0.78%. The market's positive sentiment starkly contrasted with deteriorating local economic data. Germany's consumer price inflation was confirmed at a record 10.4% in October, driven by a 43% surge in energy prices, and the UK economy officially contracted by 0.2% in the third quarter, its first decline since early 2021, although this was less severe than the -0.5% forecast. Investor behavior indicated a significant rotation, with substantial gains in cyclical and growth-sensitive names such as luxury goods (Richemont +13%), e-commerce (HelloFresh +12.5%, Zalando +11%), and industrials (Salzgitter +12%), while defensive sectors like pharmaceuticals (GSK, Sanofi, AstraZeneca) and defense (BAE Systems, Thales) saw heavy selling. This performance dispersion suggests investors are currently prioritizing forward-looking global macro developments over immediate domestic economic headwinds.

Key Decisions for Investors

• Consider re-evaluating defensive holdings, particularly in pharmaceuticals and defense which underperformed significantly, as capital appears to be rotating into cyclical and growth-sensitive sectors in response to improved global macro sentiment.
• Prioritize stock-specific catalysts over broad index movements, as seen with Richemont's 13% gain on strong sales and Salzgitter's 12% rally despite lower profits, suggesting that individual corporate outlooks can override negative macroeconomic data.
• Remain vigilant of the risk that persistent high inflation in Germany (10.4%) and the UK's economic contraction (-0.2% GDP) could eventually suppress the current optimism surrounding potential shifts in U.S. monetary policy and China's reopening.
• Exercise caution with UK-centric assets, as the FTSE 100's underperformance amid a broader European rally indicates specific domestic headwinds are actively weighing on investor confidence.